
Time to termination? <1 second. Cost of termination? $88,825.39. Seems reasonable... Posted with patient's permission. #EPeeps

Electrophysiologist @ Cardiology Consultants of Philadelphia

Time to termination? <1 second. Cost of termination? $88,825.39. Seems reasonable... Posted with patient's permission. #EPeeps

Definición del sustrato arritmogénico en la Taquicardia Ventricular relacionada con cicatriz. 🧐🔎⚡️🫀⚠️ 🔷️ La TV monomórfica relacionada con cicatriz se produce por reentrada a través de haces miocárdicos supervivientes rodeados de fibrosis. Sin embargo, no toda cicatriz es arritmogénica ni todo canal de conducción participa en el circuito de TV. 1️⃣ Sustrato anatómico (RMC/TC): identifica fibrosis, profundidad, transmuralidad y posibles corredores de conducción. Define dónde podría existir el circuito, pero no demuestra su participación. 🔄⚡️ 2️⃣ Sustrato eléctrico (mapeo de voltaje): identifica tejido eléctricamente anormal. Los umbrales bipolares convencionales de <0.5 mV (cicatriz densa) y 0.5–1.5 mV (zona limítrofe) no son límites biológicos absolutos. El voltaje unipolar puede sugerir enfermedad intramural o epicárdica no evidente en el bipolar.⚡️⚠️ 3️⃣ Sustrato funcional (ILAM y extraestímulos): identifica zonas de desaceleración (DZ), conducción decremental y bloqueo funcional. En ILAM, ≥3 isócronas concentradas en un radio de 1 cm sugieren conducción lenta localizada. La estimulación S1-S2-S3 puede desenmascarar alteraciones ausentes durante ritmo sinusal. 🧐🔎⚡️ 4️⃣ Participación directa en el circuito (mapeo durante TV): constituye la evidencia más sólida. El mapeo de activación y el entrainment permiten demostrar la relación de una región con el circuito de reentrada. 👨⚕️💬 El objetivo de la ablación no debería ser simplemente eliminar toda la cicatriz o todos los electrogramas anormales, sino identificar el miocardio superviviente funcionalmente implicado en la reentrada. La integración anatómica, eléctrica y funcional permite seleccionar objetivos más específicos. 📝🆓️⤵️ State-Of-The-Art Review2026 @JACCJournals ⚡️💯 doi.org/10.1016/j.jacep.2026… t.me/medicinainternaconsoque…

LBB Area Pacing vs RV Pacing for AV Block and Preserved Left Ventricular Function: The #LEAP-Block Trial 📍499 patients with #LVEF ≥50% randomized to LBBAP vs #RVP across 14 Chinese hospitals. 📍 Primary endpoint: 2.4% vs 12.5% favoring #LBBAP (P=0.003). 📍 HF events: 3.4% vs 11.3% with LBBAP vs RVP. 📍 LBBAP ⬇️ the 24-month primary endpoint risk (HR 0.37, 95% CI 0.19–0.73), with no significant differences in mortality or device complications. #LEAPBlock #Cardiology #HeartFailure #Pacing jamanetwork.com/journals/jam… @JAMACardio #JAMA

Credit to the EP team in Bern for this excellent remapping study after either RF or PFA. Mandated remapping is much better than remapping for symptoms jacc.org/doi/10.1016/j.jacep… A) PFA no better than RF for durable PVI B) Recapitulates GAP study showing that AF still occurs in one-third of durably isolated PVs and 72% of those with reconnected veins DID NOT have AF at one year This is the crux of our problem in EP: we don't understand the pathophysiology of the condition. PVs get isolated because we can. @TobiasReichlin

Conduction System Recovery After Pulsed Field Ablation of a Para-Hisian PVC #OpenAccess @DrMatthewHyman @PennEPFellows heartrhythmjournal.com/artic…

In patients with #HeartFailure and #LBBB, conduction system pacing (#CSP) was inferior to biventricular pacing (#BiVP) for a composite of death, heart failure events, and LVEF change at 12 months. ja.ma/3PgczJP

Among patients with heart failure and LBBB, LBBP demonstrated superior long-term clinical outcomes compared to BiVP, driven primarily by reduced rates of heart failure hospitalization. ja.ma/3PtxDwq

Explaining options to people for the first time:

This is my greatest work
Never deleting this app

Should we be surprised? PROTECT-AF (rejected by FDA) PREVAIL (did not meet NI for 2/3 PEPs) PRAGUE -17 (met NI for NACE, not for ischemic outcomes) OPTION (did not ‘win’ using procedural bleeding). Class 2 recommendation by guidelines is charitable. Enthusiasm >> evidence!

LAAC vs best medical care Thrombotic events - higher Bleeding events -- higher (counting procedure; also see AVERROES) CV death -- higher (please don't dare tell me that it was noise because if you do, let's relook at PROTECT and PREVAIL LAAC done in experienced labs #AHA25
No

Here is another look at 20,000 fps. This is less than a millisecond and was a barely perceptible spark seen with the naked eye. The electrode is touching the fabric of the device but still arcing to the underlying metallic frame.
Here is the video of PFA delivered near a LAA occlusion device

Make your A.fib clinic faster! Send this QR code or this link to your patients *before* their appointment and they'll arrive fully educated! 👍 youtu.be/oy9g9gnD9cQ

Great talk @DJ_Lakkireddy on important limitations of PFA outside of the veins. Single digit long term durability in La Fazia et al. Dual energy sources can’t come soon enough for redo ablations. There need not be discussions with current PFA iterations for VT. ahajournals.org/doi/10.1161/…

PVI+ is the one area where RCTs have been unable to supercede anecdotes – because operator bias is so powerful. Only two randomized trials have shown efficacy beyond PVI (CONVERGE and VENUS), yet only a minority have adopted. And multiple PWI studies show no systematic benefit when applied widely, yet the majority continue to do so in persistent patients. The time is ripe for personalization targeting individual mechanisms, as one size has been proven to not fit all.
What’s the obsession with PWI in AF ablation? It may appear “safe & easy” @drjohnm BUT no randomised evidence & there is downside #TWIC Oct 10

Free read at @JICE_EP. There are many variables to consider for PFA. We examined one parameter (interpulse delay) and found that lesions were larger when the time between pulses was increased, regardless of total energy delivered. rdcu.be/eMG7u